title: In reply to the comment of Dr Asaf Achiron to a paper: Circulating anti-retinal antibodies in response to anti-angiogenic therapy in exudative age-related macular degeneration.
authors.affiliation: Department of Ophthalmology, Clinic of Ophthalmology and Ocular Oncology, Jagiellonian University, Medical College, Kraków, Poland.
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Kubicka-Trząska
authors.affiliation: Institute of Molecular Biology and Clinical Genetics, Jagiellonian University Medical College, Kraków, Poland.
authors.forename: Joanna
authors.initials: J
authors.lastname: Wilańska
authors.affiliation: Department of Ophthalmology, Clinic of Ophthalmology and Ocular Oncology, Jagiellonian University, Medical College, Kraków, Poland.
authors.forename: Bożena
authors.initials: B
authors.lastname: Romanowska-Dixon
authors.affiliation: Institute of Molecular Biology and Clinical Genetics, Jagiellonian University Medical College, Kraków, Poland.
authors.forename: Marek
authors.initials: M
authors.lastname: Sanak
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001323:Autoantibodies / Q000097:blood*; D001324:Autoantigens / Q000276:immunology*; D005260:Female; D006801:Humans; D008297:Male; D012160:Retina / Q000276:immunology*; D057135:Wet Macular Degeneration / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D001323:Autoantibodies; D001324:Autoantigens